Connor Clark & Lunn Investment Management Ltd. lifted its position in ProAssurance Co. (NYSE:PRA - Free Report) by 49.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,152 shares of the insurance provider's stock after buying an additional 33,717 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned about 0.20% of ProAssurance worth $1,625,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in PRA. Summit X LLC acquired a new stake in ProAssurance during the 4th quarter valued at $382,000. Wealthfront Advisers LLC acquired a new stake in ProAssurance during the 4th quarter valued at $359,000. AlphaQuest LLC acquired a new stake in ProAssurance during the 4th quarter valued at $420,000. Amundi lifted its holdings in ProAssurance by 182.3% during the 4th quarter. Amundi now owns 25,634 shares of the insurance provider's stock valued at $389,000 after purchasing an additional 16,552 shares during the last quarter. Finally, Wakefield Asset Management LLLP acquired a new stake in ProAssurance during the 4th quarter valued at $1,036,000. 85.58% of the stock is owned by institutional investors.
ProAssurance Stock Performance
Shares of PRA traded up $0.12 during midday trading on Friday, reaching $23.14. 2,136,040 shares of the stock were exchanged, compared to its average volume of 321,699. ProAssurance Co. has a twelve month low of $10.76 and a twelve month high of $23.29. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.35. The company has a market cap of $1.18 billion, a P/E ratio of 27.88 and a beta of 0.21. The stock's 50 day simple moving average is $15.40 and its 200 day simple moving average is $15.40.
ProAssurance (NYSE:PRA - Get Free Report) last posted its earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.19. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. The company had revenue of $287.52 million during the quarter, compared to the consensus estimate of $274.56 million. On average, sell-side analysts expect that ProAssurance Co. will post 0.8 earnings per share for the current year.
Analysts Set New Price Targets
Separately, StockNews.com downgraded ProAssurance from a "buy" rating to a "hold" rating in a report on Friday.
View Our Latest Research Report on PRA
ProAssurance Company Profile
(
Free Report)
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Recommended Stories

Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.